These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5515417)

  • 1. Effect of reserpine on the incorporation in vivo of radioactivity from labeled serotonin and other 5-hydroxy-indole derivatives in mouse brain.
    Alivisatos SG; Ungar F; Seth PK; Levitt LP
    Biochem Pharmacol; 1970 Feb; 19(2):401-10. PubMed ID: 5515417
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain.
    Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
    Biochem Pharmacol; 1969 Aug; 18(8):1971-8. PubMed ID: 5811629
    [No Abstract]   [Full Text] [Related]  

  • 3. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution and metabolism of tryptamine in rat brain.
    Wu PH; Boulton AA
    Can J Biochem; 1973 Jul; 51(7):1104-12. PubMed ID: 4725358
    [No Abstract]   [Full Text] [Related]  

  • 5. Incorporation of radioactivity from labeled serotonin and tryptamine into acid-insoluble material from subcellular fractions of brain. I. The nature of the substrate.
    Alivisatos SG; Ungar F
    Biochemistry; 1968 Jan; 7(1):285-92. PubMed ID: 5312358
    [No Abstract]   [Full Text] [Related]  

  • 6. A convenient method for the chromatographic analysis of norepinephrine, dopamine, and serotonin.
    Minard FN; Grant DS
    Biochem Med; 1972 Feb; 6(1):46-52. PubMed ID: 5023887
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
    Korduba CA; Veals J; Symchowicz S
    J Pharmacol Exp Ther; 1974 Sep; 190(3):459-65. PubMed ID: 4413186
    [No Abstract]   [Full Text] [Related]  

  • 8. Behaviour of rats and biogenic amine level in brain after 6-hydroxy-dopamine.
    Herman ZS; Kmieciak-Kolada K; Brus R
    Psychopharmacologia; 1972; 24(3):407-16. PubMed ID: 5034941
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase dependent labeling in vivo of mouse brain by 14C-serotonin.
    Alivisatos SG; Ungar F; Parmar SS; Seth PK
    Biochem Pharmacol; 1968 Sep; 17(9):1993-5. PubMed ID: 5688280
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG; Lovell RA; Freedman DX
    Biochem Pharmacol; 1973 Sep; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 6-methoxy-1,2,3,4-tetrahydro- -carboline on the regional and subcellular distribution of serotonin in mouse and rat brains.
    Ho BT; Taylor D; Askew WE; McIsaac WM
    Life Sci I; 1972 May; 11(10):493-502. PubMed ID: 4540330
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of reserpine on recovery rates after inhibition of monoamine oxidase in different regions of mouse brain.
    Hall TR; Yurgens PB; Figueroa HR
    Gen Pharmacol; 1984; 15(6):485-9. PubMed ID: 6526260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychotropic drugs and the metabolism of intracerebrally injected tryptamine, 5-hydroxytryptamine, and norepinephrine.
    Meek JL; Krall AR; Lipton MA
    J Neurochem; 1970 Dec; 17(12):1627-35. PubMed ID: 5492984
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain.
    Cascio CS; Kellar KJ
    Eur J Pharmacol; 1986 Jan; 120(1):101-5. PubMed ID: 3948908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevancy of changes in cerebral 5-hydroxytryptamine to reserpine-produced sedation.
    Gál EM; Millard SA
    Biochem Pharmacol; 1968 Oct; 17(10):2193-203. PubMed ID: 5696885
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of monoamineoxidase inhibitors on 5-hydroxytryptamine output from perfused cerebral ventricles of anaesthetized cats.
    Goodrich CA
    Br J Pharmacol; 1969 Sep; 37(1):87-93. PubMed ID: 4390487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.